HealthcareChina
China Updates Essential Drug List, Adds Innovative Drugs
China releases 2026 National Essential Drug List with 794 varieties, including innovative drugs for the first time in a landmark policy shift.
—5 min read
Tag
#Pharmaceutical Policy
4 articles
HealthcareEconomy
China Drug Procurement: From Lowest Price to Clinical Value
China's 12th drug procurement round shifts focus to clinical value, with anti-involution measures and a revival mechanism for originator drugs.
—4 min read
HealthcarePolicy
China Launches 2026 Dual Drug Catalog for Innovation Access
China's NHSA launches 2026 dual catalog adjustment for medical and commercial insurance, introducing pre-application mechanisms and expanded eligibility.
—4 min read
Policy & EconomyTechnology
China Issues First Policy on Marine Biomedical Industry
China releases its first national policy for the marine biomedical industry, targeting 130 billion yuan in added value and multiple new drugs by 2030.
—4 min read